Furthermore, EGLN1 blockade was determined to have a beneficial impact on atherosclerosis by reducing approximately 50% of atherosclerotic plaque areas and macrophage numbers in white adipose tissue, increasing autoantibodies against oxidized LDL [34, 35]. This evidence concerns the gene EGLN1 and atherosclerosis.